This study tested a new drug called IRX-101 to see if it reduces pain and damage to the eye's surface after common sight-saving injections. 155 adults with retinal disease received either IRX-101 or a standard cleaning solution before their injection. The goal was to make the pro…
Phase: PHASE2 • Sponsor: iRenix Medical, Inc. • Aim: Symptom relief
Last updated Jun 08, 2026 13:13 UTC